Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05551117
Title A Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer (Tamarack)
Acronym Tamarack
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors MacroGenics
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | BEL | AUS

No variant requirements are available.